/
KNBIF
$0.02+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.04
11% from low
Exchange
OTC Link
OS
Borrow rate
0.31%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.11
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $506.3K | $1.7M | $1.3M | $1.6M | $2.7M | $149.0K | $2.1M | $427.5K |
| Cost of revenue | $390.8K | $1.1M | $814.7K | $1.0M | $1.3M | $39.5K | $1.2M | $590.8K |
| Gross profit | $115.5K | $609.9K | $526.9K | $568.4K | $1.4M | $109.5K | $872.1K | −$163.2K |
| Gross margin | 22.8% | 36.0% | 39.3% | 35.4% | 53.0% | 73.5% | 41.9% | -38.2% |
| R&D | $922.5K | $1.5M | $1.3M | $1.4M | $1.1M | $1.3M | $1.7M | $867.2K |
| Operating income | −$3.2M | −$3.6M | −$4.2M | −$4.9M | −$3.5M | −$3.4M | −$3.9M | −$3.1M |
| EBITDA | −$3.1M | −$764.1K | −$3.6M | −$4.2M | −$2.9M | −$3.2M | −$3.7M | −$2.9M |
| Net income | −$3.3M | −$960.2K | −$3.7M | −$4.6M | −$3.9M | −$5.0M | $6.1M | −$2.7M |
| Net margin | -644.1% | -56.7% | -277.0% | -286.4% | -145.8% | -3379.0% | 293.0% | -636.0% |
| EPS (diluted) | -0.04 | -0.01 | -0.03 | -0.04 | -0.03 | -0.04 | -0.02 | -0.02 |
Annual figures · source: Financial Modeling Prep
Peer comparison
KANE BIOTECH INC ORD
KANE BIOTECH INC ORD
Held by traders on TradeandTell
No one on the platform currently holds KNBIF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in KNBIF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2017-03-13 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded KNBIF yet.